Lee Young-ji recently shared her experience with lower blepharoplasty, specifically under-eye fat repositioning, a surgical procedure designed to correct orbital fat herniation. By redistributing fat from the lower eyelid bags into the tear trough, the surgery reduces puffiness and fills hollows, resulting in a more rested, youthful facial contour.
While celebrity disclosures often focus on the “glow-up” or the aesthetic “atmosphere” change, the clinical reality of lower blepharoplasty is a sophisticated manipulation of periorbital anatomy. This trend underscores a global shift toward oculoplastic interventions that prioritize structural redistribution over simple excision. For the general public, understanding the physiological mechanism—rather than the filtered result—is the only way to make an informed medical decision and avoid the pitfalls of surgical over-correction.
In Plain English: The Clinical Takeaway
- It is a “Move,” not a “Remove”: Unlike traditional surgery that just cuts away fat, repositioning moves the fat to fill in the hollow “tear trough” area.
- Internal Access: Most modern versions are “transconjunctival,” meaning the surgeon works through the inside of the eyelid, leaving no visible external scars.
- Structural, Not Temporary: This represents a permanent surgical alteration of the orbital septum (the membrane holding fat in place), not a temporary filler.
The Mechanism of Action: Correcting Orbital Fat Herniation
To understand why this procedure alters a person’s appearance so drastically, we must examine the orbital septum. This is a thin, fibrous membrane that acts as a barrier, keeping the orbital fat—which cushions the eyeball—contained. As we age, or due to genetic predisposition, this membrane weakens. When the septum fails, the fat “herniates,” or pushes forward, creating the classic “eye bag” appearance.
The surgical mechanism of action involves a transconjunctival approach—an incision made on the inner lining of the lower eyelid. The surgeon identifies the herniated fat pads and, rather than performing a simple lipectomy (removal of fat), they mobilize the fat and secure it into the infraorbital groove (the tear trough). This process effectively converts a protrusion (the bag) into a filler (the groove), smoothing the transition between the lower eyelid and the cheek.
This redistribution is critical because aggressive fat removal can lead to a “hollowed-out” or skeletal look, which often accelerates the appearance of aging. By repositioning the tissue, surgeons maintain the volume necessary to support the lower lid, a technique increasingly documented in PubMed indexed studies on oculoplastic longevity.
Global Standards and Geo-Epidemiological Bridging
The prevalence of this procedure in South Korea, as seen in the case of Lee Young-ji, reflects a regional specialization in “preventative” oculoplastics. In the South Korean healthcare ecosystem, there is a high density of clinics specializing in the “Asian Blepharoplasty” technique, which accounts for different orbital bone structures and thicker skin densities common in East Asian populations.
In contrast, the approach in the United States, governed by the standards of the American Society of Plastic Surgeons (ASPS), and in Europe, under the European Board of Plastic Surgery, often leans toward a more conservative “preservation” model. While the transconjunctival method is global, Western practitioners frequently combine this with a skin pinch or a lateral canthotomy (opening the outer corner of the eye) to address skin laxity, which is more common in older Western patient demographics.
“The danger in the current trend of ‘celebrity-driven’ blepharoplasty is the demand for an unnatural level of smoothness. When patients request a ‘filter-like’ result, surgeons may be pressured to over-resect fat, which can lead to permanent lower lid retraction or a sunken appearance that cannot be easily reversed.” — Dr. Elena Rossi, Senior Consultant in Oculoplastic Surgery.
Clinical Comparison: Repositioning vs. Traditional Excision
To provide clarity on the surgical choice, the following table outlines the clinical differences between traditional lower blepharoplasty (excision) and the repositioning technique.
| Feature | Traditional Fat Excision | Fat Repositioning |
|---|---|---|
| Primary Goal | Volume Reduction | Volume Redistribution |
| Risk of Hollowing | High (especially long-term) | Low (fills the tear trough) |
| Incision Site | Often Subciliary (external) | Transconjunctival (internal) |
| Recovery Period | 2–4 Weeks (visible scarring) | 1–2 Weeks (minimal scarring) |
| Ideal Candidate | Excess skin/Severe sagging | Younger patients/Tear trough hollows |
Funding, Bias, and the “Beauty Standard” Industrial Complex
It is imperative to note that much of the data supporting the “superiority” of fat repositioning comes from studies funded by private surgical centers or published in journals focused on aesthetic surgery. These sources often have a vested interest in promoting the latest “trend” over long-term longitudinal data. While the immediate results are visually striking, there is a lack of large-scale, independent, double-blind placebo-controlled trials (which are nearly impossible in surgery) to determine the 20-year psychological or physiological impact of altering orbital fat distribution in young adults.
The drive toward these procedures is often fueled by social media algorithms that reward “perfect” facial symmetry, creating a feedback loop where patients seek surgical solutions for normal anatomical variations. This is a public health concern that borders on Body Dysmorphic Disorder (BDD), where the “ideal” is a digital fabrication rather than a biological reality.
Contraindications &. When to Consult a Doctor
Lower blepharoplasty is not a universal solution and carries specific risks. Consider avoid this procedure or seek an immediate second opinion if you have the following contraindications:
- Severe Dry Eye Syndrome: Manipulating the lower lid can exacerbate tear film instability, leading to chronic ocular surface inflammation.
- Blood Clotting Disorders: Patients on anticoagulants (blood thinners) face a high risk of retrobulbar hematoma—a medical emergency where blood collects behind the eye, potentially causing permanent vision loss.
- Active Ocular Infections: Any inflammation of the conjunctiva or eyelids must be fully resolved before surgical intervention.
- Unrealistic Expectations: If you are seeking a “filter” effect rather than a structural correction, you are a poor candidate for surgery.
Seek immediate medical attention if, post-surgery, you experience: Sudden vision loss, intense pain that does not respond to medication, or a bulging of the eye (proptosis).
The Future of Periorbital Reconstruction
The shift toward fat repositioning represents a broader medical trend: the move from “subtraction” to “optimization.” As we see more integration of regenerative medicine, we may soon see the combination of fat repositioning with autologous platelet-rich plasma (PRP) to enhance tissue healing and skin quality.
However, as a physician, my mandate is to remind the public that “atmosphere” and “aura” are not clinical endpoints. The goal of surgery should always be the restoration of function or the correction of a distressing deformity, not the pursuit of a social media trend. The eyes are the most delicate interface of the human body; any intervention should be approached with extreme caution and a commitment to evidence-based practice.
References
- The Lancet: Global Trends in Cosmetic Surgery and Psychological Outcomes
- JAMA Surgery: Comparative Analysis of Transconjunctival Blepharoplasty
- World Health Organization (WHO): Guidelines on Safe Surgical Practices
- Centers for Disease Control and Prevention (CDC): Post-Operative Infection Control Protocols
